top of page
A framework to support new product introduction in national health systems
Resource Library

Pediatric DRV/r (pDRV/r) FAQs
This document is meant to answer some of the most common questions that surround pediatric darunavir/ritonavir 120/20mg (pDRV/r) - a new...
Sep 6, 2023
169

Pediatric DRV/r (pDRV/r) Product Profile
This product profile provides a clinical overview of the best-in-class protease inhibitor (PI) formulated in a fixed-dose combination...
Sep 6, 2023
170

Pediatric ALD (pALD) FAQs
This document is meant to answer some of the most common questions surround the fixed-dose combination of pediatric...
Jun 5, 2023
309

pALD Product Profile
This product profile provides a clinical overview of the fixed-dose combination of pediatric abacavir/lamivudine/ dolutegravir 60/30/5 mg...
May 30, 2023
1,346

CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
Mar 17, 2022
177

CHAI Pediatric DTG Product Profile
This product profile provides a clinical overview of pediatric DTG, market updates and implementation considerations, and provides...
Oct 12, 2021
145

TLD Resources
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
Aug 1, 2018
77

CHAI TLD Product Profile
This presentation provides a broad overview of the benefits of DTG-containing regimens, the advantages of fixed-dose combination ARVs,...
Aug 1, 2017
15

CHAI Pediatric LPV/r Oral Pellets Product Profile
This presentation provides a broad overview of pediatric LPV/r oral pellets, guidance on administration, and key considerations for...
Jan 1, 2017
9
bottom of page